Children with HIV in whom antiretroviral therapy (ART) was interrupted at either 12 or 24 months had lower geometric mean titers (GMTs) and lower proportions with seroprotective measles antibody titers than HIV-unexposed children, indicating a potential downside of ART treatment interruption. This according to a recent cohort study that followed participants from 6-12 weeks though 4.5 years of age. HIV-unexposed (n=95), HIV-exposed-uninfected (HEU; n=84), HIV/Immed-ART-12 (n=70), HIV/Immed-ART-24 (n=70), and HIV/Def-ART (n=62) children were scheduled to receive measles vaccination at 9 and 15-18 months of age. Anti-measles serum IgG titers were quantified at 4.5 years. Researchers found:
- Compared with HIV-unexposed children, GMTs were significantly lower in both HIV/Immed-ART-12 and HIV/Immed-ART-24, but similar in the HIV/Def-ART and HEU.
- Also, antibody titers ≥330 mIU/mL were significantly lower in HIV/Immed-ART-12 and HIV/Immed-24 when compared with HIV-unexposed, but were similar in the HIV/Def-ART and HEU groups.
- These results indicate a potential downside of ART treatment interruption.
Mutsaerts EAML, Nunes MC, van Rijswijk MN, et al. Measles immunity at 4.5 years of age following vaccination at 9 and 15-18 months of age among HIV-infected, HIV-exposed-uninfected and HIV-unexposed children. [Published online ahead of print November 12, 2018]. Clin Infect Dis. doi:10.1093/cid/ciy964.
There have been studies that hypothesized that if children receive early onset ART, close to primary infection, that children could be permitted some time off ART. This study would show that in children in whom ART is interrupted, the response to measles vaccination may be decreased. This might need to be accounted for in immunization schedules for HIV positive children and adolescents that are on an interrupted ART schedule or not on ART at the time of measles immunization. It did show that if vaccination is given during ART, then responses are comparable to healthy children. —John Russell, MD
This Week's Must Reads
Acute Illness and Cannabis Use in Adults, Ann Intern Med; ePub 2019 Mar 26; Monte, et al
Must Reads in Vaccines
Vaccination for Prevention of Herpes Zoster, Ann Intern Med; ePub 2019 Feb 19; Prosser, et al
ACIP Updates Adult Immunization Schedule, Ann Intern Med; 2019 Feb 5; Kim, Hunter, et al
Influenza Vaccination Safety During Hospitalization, Mayo Clin Proc; ePub 2019 Jan 8; Tartof, et al
Acellular Pertussis Vaccine Is Safe & Effective, JAMA Pediatr; 2018 Nov; Wood, Nolan, et al
Influenza and Pertussis Vaccination in Pregnancy, Vaccine; ePub 2018 Nov 3; Wilcox, Bottrell, et al